The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(4-methoxyphenyl)-2-(morpholinomethyl)thieno[3,2-b]pyridine-5-carboxamide ID: ALA4513332
PubChem CID: 155538978
Max Phase: Preclinical
Molecular Formula: C20H21N3O3S
Molecular Weight: 383.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2cc(C(N)=O)nc3cc(CN4CCOCC4)sc23)cc1
Standard InChI: InChI=1S/C20H21N3O3S/c1-25-14-4-2-13(3-5-14)16-11-18(20(21)24)22-17-10-15(27-19(16)17)12-23-6-8-26-9-7-23/h2-5,10-11H,6-9,12H2,1H3,(H2,21,24)
Standard InChI Key: VAGJZHYRXRYBBV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
8.0561 -18.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7657 -18.4505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7629 -17.6279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0543 -17.2226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0578 -19.6750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3483 -20.0828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3478 -20.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0559 -21.3088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7661 -20.8960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7631 -20.0809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3480 -18.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3492 -17.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5731 -17.3810 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0921 -18.0409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5711 -18.7021 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.2749 -18.0397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8653 -18.7468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4691 -17.2166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1783 -17.6226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.4660 -16.3994 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0568 -22.1260 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3495 -22.5354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0481 -18.7445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6386 -19.4475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0427 -20.1582 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8608 -20.1614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2749 -19.4538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 12 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 11 1 0
14 16 1 0
16 17 1 0
3 18 1 0
18 19 1 0
18 20 2 0
8 21 1 0
21 22 1 0
17 23 1 0
17 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.47Molecular Weight (Monoisotopic): 383.1304AlogP: 2.90#Rotatable Bonds: 5Polar Surface Area: 77.68Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.69CX LogP: 2.60CX LogD: 2.52Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.73Np Likeness Score: -1.20
References 1. Childress ES, Wieting JM, Felts AS, Breiner MM, Long MF, Luscombe VB, Rodriguez AL, Cho HP, Blobaum AL, Niswender CM, Emmitte KA, Conn PJ, Lindsley CW.. (2018) Discovery of Novel Central Nervous System Penetrant Metabotropic Glutamate Receptor Subtype 2 (mGlu2 ) Negative Allosteric Modulators (NAMs) Based on Functionalized Pyrazolo[1,5- a]pyrimidine-5-carboxamide and Thieno[3,2- b]pyridine-5-carboxamide Cores., 62 (1): [PMID:30350962 ] [10.1021/acs.jmedchem.8b01266 ]